David A. Rizzieri - Concepedia

Author

David A. Rizzieri

Also Known As

Corbet, Kelly, D A Rizzieri, D Rizzieri, D. A. Rizzieri, D. Rizzieri, D.A Rizzieri, D.A. Rizzieri, DAVID A. RIZZIERI, David A Rizzieri, David A. Rizzieri

587

Publications

17.7K

Citations

H-Index

120

Concepts

All Affiliations

Duke Medical Center Duke University The University of Texas MD Anderson Cancer Center Fred Hutch Cancer Center Duke University Hospital

About

David A. Rizzieri is an author at Duke Medical Center specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	77	5.1K
2	Health Sciences	20	28	2.8K
3	Public Health	3	3	72
4	Arts	1	1	41
5	Natural Sciences	1	1	33

David A. Rizzieri

214

Publications

15.7K

Citations

H-Index

Page 1

	Year	Citations
Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors Mary J. Laughlin, Juliet N. Barker, Barbara Bambach, New England Journal of Medicine	2001	878
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia Chen Zhao, Alan Chen, Catriona Jamieson, Nature Tumor BiologyDevelopmental BiologyMedicineHedgehog SignallingAdult Stem Cell	2009	852
Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells Mónica L. Guzmán, Sarah J. Neering, Donna Upchurch, Blood	2001	752
The genetic landscape of mutations in Burkitt lymphoma Cassandra Love, Zhen Sun, Dereje D. Jima, Nature Genetics Genetic LandscapeLymphoid NeoplasiaSomatic VariantGenetic DisorderMedicine	2012	595
Genetic heterogeneity of diffuse large B-cell lymphoma Jenny Zhang, Vladimir Grubor, Cassandra Love, Proceedings of the National Academy of Sciences	2013	530
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia Eytan M. Stein, Guillermo Garcia‐Manero, David A. Rizzieri, Blood	2018	442
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial Philippe Armand, Arnon Nagler, Edie Weller, Journal of Clinical Oncology	2013	437
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure Michel Duval, John P. Klein, Wensheng He, Journal of Clinical Oncology Cell TherapyMixed-phenotype Acute LeukemiaBetter PrognosisPrimary Induction FailureAcute Leukemia	2010	437
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States Lori Muffly, Marcelo C. Pasquini, Michael J. Martens, Blood	2017	281
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study Jean‐Pierre J. Issa, Gail J. Roboz, David A. Rizzieri, The Lancet Oncology Hematological MalignancyDose-escalation Phase 1OncologyMyelodysplastic SyndromeMixed-phenotype Acute Leukemia	2015	280

Page 1